These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38577604)

  • 1. Construction and multicohort validation of a colon cancer prognostic risk score system based on big data of neutrophil-associated differentially expressed genes.
    Yang Y; Lu C; Li L; Zheng C; Wang Y; Chen J; Sun B
    J Cancer; 2024; 15(9):2866-2879. PubMed ID: 38577604
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
    Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
    Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
    Chai R; Zhao Y; Su Z; Liang W
    Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical prognostic model of oxidative stress-related genes linked to tumor immune cell infiltration and the prognosis of ovarian cancer patients.
    Li L; Zhang W; Sun Y; Zhang W; Lu M; Wang J; Jin Y; Xi Q
    Heliyon; 2024 Apr; 10(7):e28442. PubMed ID: 38560253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constructing and validating a risk model based on neutrophil-related genes for evaluating prognosis and guiding immunotherapy in colon cancer.
    Wang S; Wang L; Qiu M; Lin Z; Qi W; Lv J; Wang Y; Lu Y; Li X; Chen W; Qiu W
    J Gene Med; 2024 Apr; 26(4):e3684. PubMed ID: 38618694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
    Chen L; Lin J; Wen Y; Chen Y; Chen CB
    Front Oncol; 2023; 13():1291720. PubMed ID: 38023241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
    Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
    J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer.
    Gu L; Hu G; Hu J; Wen F
    Heliyon; 2023 Aug; 9(8):e18848. PubMed ID: 37593621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W
    Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes.
    Jiang HZ; Yang B; Jiang YL; Liu X; Chen DL; Long FX; Yang Z; Tang DX
    Front Oncol; 2022; 12():1025397. PubMed ID: 36387195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
    Jin Y; Deng J; Luo B; Zhong Y; Yu S
    Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of angiogenesis-related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancer.
    Wang F; Wang C; Li B; Wang G; Meng Z; Han J; Guo G; Yu B; Wang G
    Biotechnol Appl Biochem; 2024 Feb; 71(1):45-60. PubMed ID: 37881150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.